8- (4- Methoxyphenylthio)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-pMeOPT-2'-O-Me-cAMP )

Potent Epac agonist
Cat. No.: M 034   CAS No.: [612513-16-3]   Bulk available
Product Image



C18H19N5O7PS•Na; MW 503.4; λmax 282 nm; ε 16000; sodium salt; purity > 98% HPLC. For other salt forms please inquire. Very potent and specific activator of the exchange protein activated by cyclic AMP (Epac) or cAMP-GEF, respectively, which does not activate protein kinase A. High lipophilicity and membrane permeability, as well as increased PDE stability. Detailed technical information and updated references available. References: Christensen et al., J. Biol. Chem., 278, 35394 - 35402 (2003); Holz et al., J. Physiol., 577, 5 – 15 (2006).

Protected by patent n° EP 02077219.0 and foreign equivalents, exclusively licensed to BIOLOG LSI for research purposes only

 



Forgot your password?
Register
Username:
Password:
What is new!

June 07, 2010

New NAD and cADPR analogues !

Latest additions to our expanding product line of NAD+ and cADPR analogues are:

8-Br-7-CH-cADP... [more...]

May 21, 2010

New Epac references !

Two new collaborative papers describing the use of the membrane-permeant Epac activator... [more...]